Romano MR and Lograno MD |
Cannabinoid agonists induce relaxation in the bovine ophthalmic artery: evidences for CB1 receptors, nitric oxide and potassium channels. |
2006 |
Br. J. Pharmacol. |
pmid:16474412
|
GarcÃa Mdel C et al. |
Role of CGRP and GABA in the hypotensive effect of intrathecally administered anandamide to anesthetized rats. |
2006 |
Eur. J. Pharmacol. |
pmid:16472800
|
Cupini LM et al. |
Biochemical changes in endocannabinoid system are expressed in platelets of female but not male migraineurs. |
2006 |
Cephalalgia |
pmid:16472333
|
Glaser ST et al. |
Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide. |
2005 Nov-Dec |
Vis. Neurosci. |
pmid:16469181
|
Gough NR |
Focus issue: signaling lipids. |
2006 |
Sci. STKE |
pmid:16467192
|
Waku K |
[Endogenous cannabinoid receptor ligands--anandamide and 2-arachidonoylglycerol]. |
2006 |
Yakugaku Zasshi |
pmid:16462096
|
Kaczocha M et al. |
Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase. |
2006 |
J. Biol. Chem. |
pmid:16461355
|
Tuccinardi T et al. |
Cannabinoid CB2/CB1 selectivity. Receptor modeling and automated docking analysis. |
2006 |
J. Med. Chem. |
pmid:16451064
|
Guindon J and Beaulieu P |
Antihyperalgesic effects of local injections of anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain. |
2006 |
Neuropharmacology |
pmid:16442133
|
Ueda N and Tsuboi K |
[Enzymes involved in the biosynthesis and degradation of anandamide]. |
2005 |
Seikagaku |
pmid:16440755
|
Schelling G et al. |
Effects of general anesthesia on anandamide blood levels in humans. |
2006 |
Anesthesiology |
pmid:16436846
|
Murillo-Rodriguez E et al. |
Diurnal variation of arachidonoylethanolamine, palmitoylethanolamide and oleoylethanolamide in the brain of the rat. |
2006 |
Life Sci. |
pmid:16434061
|
Marx J |
Drug development. Drugs inspired by a drug. |
2006 |
Science |
pmid:16424309
|
Meuth SG et al. |
The contribution of TWIK-related acid-sensitive K+-containing channels to the function of dorsal lateral geniculate thalamocortical relay neurons. |
2006 |
Mol. Pharmacol. |
pmid:16424077
|
Guagnini F et al. |
Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P. |
2006 |
Gut |
pmid:16423891
|
Bermúdez-Siva FJ et al. |
Activation of cannabinoid CB1 receptors induces glucose intolerance in rats. |
2006 |
Eur. J. Pharmacol. |
pmid:16423347
|
Kohro S et al. |
Anandamide absorption by direct hemoperfusion with polymixin B-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis. |
2006 |
J Anesth |
pmid:16421670
|
Salo OM et al. |
3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data. |
2006 |
J. Med. Chem. |
pmid:16420041
|
Siegmund SV et al. |
Fatty acid amide hydrolase determines anandamide-induced cell death in the liver. |
2006 |
J. Biol. Chem. |
pmid:16418162
|
Voets T et al. |
Sensing with TRP channels. |
2005 |
Nat. Chem. Biol. |
pmid:16408004
|
Yang YY et al. |
Roles of anandamide in the hepatic microcirculation in cirrhotic rats. |
2006 |
Am. J. Physiol. Gastrointest. Liver Physiol. |
pmid:16407591
|
Appendino G et al. |
First "hybrid" ligands of vanilloid TRPV1 and cannabinoid CB2 receptors and non-polyunsaturated fatty acid-derived CB2-selective ligands. |
2006 |
FEBS Lett. |
pmid:16406364
|
Nakajima Y et al. |
Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-kappaB pathway inhibition. |
2006 |
FEBS Lett. |
pmid:16406050
|
D'Argenio G et al. |
Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation. |
2006 |
FASEB J. |
pmid:16403786
|
Eljaschewitsch E et al. |
The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. |
2006 |
Neuron |
pmid:16387640
|
Bai X et al. |
TASK channel expression in human placenta and cytotrophoblast cells. |
2006 |
J. Soc. Gynecol. Investig. |
pmid:16378911
|
Ligresti A et al. |
Endocannabinoid metabolic pathways and enzymes. |
2005 |
Curr Drug Targets CNS Neurol Disord |
pmid:16375679
|
Bojesen IN and Hansen HS |
Effect of an unstirred layer on the membrane permeability of anandamide. |
2006 |
J. Lipid Res. |
pmid:16365480
|
Gobbi G et al. |
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. |
2005 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:16352709
|
Varvel SA et al. |
Fatty acid amide hydrolase (-/-) mice exhibit an increased sensitivity to the disruptive effects of anandamide or oleamide in a working memory water maze task. |
2006 |
J. Pharmacol. Exp. Ther. |
pmid:16352706
|
Siegmund SV and Brenner DA |
Molecular pathogenesis of alcohol-induced hepatic fibrosis. |
2005 |
Alcohol. Clin. Exp. Res. |
pmid:16344593
|
Grimaldi C et al. |
Anandamide inhibits adhesion and migration of breast cancer cells. |
2006 |
Exp. Cell Res. |
pmid:16343481
|
Lizanecz E et al. |
Phosphorylation-dependent desensitization by anandamide of vanilloid receptor-1 (TRPV1) function in rat skeletal muscle arterioles and in Chinese hamster ovary cells expressing TRPV1. |
2006 |
Mol. Pharmacol. |
pmid:16338989
|
Flygare J et al. |
Cannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphoma. |
2005 |
FEBS Lett. |
pmid:16337199
|
Hejazi N et al. |
Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors. |
2006 |
Mol. Pharmacol. |
pmid:16332990
|
Rösch S et al. |
R(+)-methanandamide and other cannabinoids induce the expression of cyclooxygenase-2 and matrix metalloproteinases in human nonpigmented ciliary epithelial cells. |
2006 |
J. Pharmacol. Exp. Ther. |
pmid:16330497
|
Cannizzaro C et al. |
Presynaptic effects of anandamide and WIN55,212-2 on glutamatergic nerve endings isolated from rat hippocampus. |
2006 |
Neurochem. Int. |
pmid:16325966
|
Juan-Picó P et al. |
Cannabinoid receptors regulate Ca(2+) signals and insulin secretion in pancreatic beta-cell. |
2006 |
Cell Calcium |
pmid:16321437
|
Suplita RL et al. |
Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia. |
2006 |
Neuropharmacology |
pmid:16316669
|
Mechoulam R and Deutsch DG |
Toward an anandamide transporter. |
2005 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:16314567
|
Bir LS and Ercan S |
Effects of intrathecal anandamide on somatosensory evoked responses in rats. |
2006 |
Exp. Neurol. |
pmid:16289169
|
Ligresti A et al. |
New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosis. |
2006 |
Br. J. Pharmacol. |
pmid:16284631
|
Brizzi A et al. |
Design, synthesis, and binding studies of new potent ligands of cannabinoid receptors. |
2005 |
J. Med. Chem. |
pmid:16279794
|
Glaser ST et al. |
Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain. |
2006 |
J. Pharmacol. Exp. Ther. |
pmid:16278311
|
Kadoi Y et al. |
Cannabinoid antagonist AM 281 reduces mortality rate and neurologic dysfunction after cecal ligation and puncture in rats. |
2005 |
Crit. Care Med. |
pmid:16276190
|
Sarnataro D et al. |
Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells. |
2005 |
FEBS Lett. |
pmid:16263116
|
Kim HI et al. |
Anandamide suppression of Na+ currents in rat dorsal root ganglion neurons. |
2005 |
Brain Res. |
pmid:16256960
|
Cabranes A et al. |
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. |
2005 |
Neurobiol. Dis. |
pmid:16242629
|
Di S et al. |
Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus. |
2005 |
J. Physiol. (Lond.) |
pmid:16239276
|
Malfitano AM et al. |
Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis. |
2006 |
J. Neuroimmunol. |
pmid:16239036
|